BRSF — Brain Scientific Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Brain Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.43 | -1 | -4.28 | -9.1 | -12.3 |
| Depreciation | |||||
| Non-Cash Items | 0.083 | 0.031 | 2.48 | 3.27 | 5.49 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.23 | 0.117 | 0.626 | -0.259 | 0.118 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.11 | -0.855 | -1.17 | -5.87 | -5.94 |
| Capital Expenditures | -0.001 | -0.001 | — | -0.059 | -0.033 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.001 | -0.001 | — | -0.059 | -0.033 |
| Financing Cash Flow Items | — | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.98 | 0.953 | 1.19 | 6.65 | 5.93 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.134 | 0.098 | 0.011 | 0.716 | -0.038 |